Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Lack of Sleep, Transition to SLE, May Be Linked

Lupus; ePub 2018 May 28; Young, Munroe, et al

Lack of sleep may be associated with transitioning to systemic lupus erythematosus (SLE), independent of early clinical manifestations of SLE that may influence sleep duration, a recent study found. 436 relatives of SLE patients who did not have SLE themselves at baseline were evaluated again an average of 6.3 (± 3.9) years later. 56 individuals transitioned to SLE (≥4 cumulative American College of Rheumatology [ACR] criteria). Sleep duration, medication use, and medical history were assessed by questionnaire; ACR criteria were confirmed by medical record review. Researchers found:

  • Reporting sleeping <7 hours per night at baseline was more common in those who subsequently transitioned than those who did not transition to SLE (55% vs 32%).
  • Those who transitioned to SLE were more likely to sleep <7 hours per night than those who did not transition to SLE adjusting for age, sex, and race.
  • This association remained after individual adjustment for conditions and early symptoms that could affect sleep, including prednisone use, vitamin D deficiency, and number of ACR criteria.

Citation:

Young KA, Munroe ME, Harley JB, et al. Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus. [Published online ahead of print May 28, 2018]. Lupus. doi:10.1177/0961203318778368.

This Week's Must Reads

Long-term Opioid Use with Severe OA by Geography, Arthritis Rheumatol; ePub 2019 Jan 28; Desai, et al

Family History of Psoriasis and Psoriatic Disease, Arthritis Care Res; ePub 2019 Jan 25; Solmaz, et al

Remission/Low Disease Activity Protective in SLE , Lupus; ePub 2019 Jan 24; Alarcón, Ugarte-Gil, et al

Dietary Niacin Linked with Incident Hip Fracture, J Bone Miner Res; ePub 2019 Jan 19; Carbone, et al

Must Reads in Lupus & Connective Tissue Diseases

Remission/Low Disease Activity Protective in SLE , Lupus; ePub 2019 Jan 24; Alarcón, Ugarte-Gil, et al

List of medications linked to drug-induced lupus expands, Arnaud L et al. Ann Rheum Dis. 2019 Feb 4. doi: 10.1136/annrheumdis-2018-214598

Ehlers-Danlos syndrome: Increased IUGR risk reported, Nicholls-Dempsey L et al. Am J Obstet Gynecol. 2019 Jan;220(1):S381-382. Abstract 574

Measurement Tools for Patients with SSc and GERD, J Rheumatol; 2019 Jan; McMahan, Frech, et al

Independent Contributors to Fatigue in SLE, Lupus; ePub 2018 Dec 22; Azizoddin, et al